Safety and Effectiveness of Omega 3-Fatty Acids, EPA Versus DHA, for the Treatment of Major Depression
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
This study examines the difference in the effectiveness of two natural compounds,
eicosapentanoic (EPA) and docosahexanoic (DHA)omega-3 fatty acids, in treating major
depressive disorder. Both types of omega-3 fatty acids are commonly found in fish oils. It is
believed that a deficiency in these omega-3 fatty acids may lead to the development of major
depression.
Phase:
Phase 3
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborators:
Cedars-Sinai Medical Center National Institute of Mental Health (NIMH)